Skip to main content
SpringerLink
Log in

Prävention der Exazerbation bei COPD

Rolle einer Dauertherapie mit Azithromycin

Prevention of exacerbation of COPD

Role of long-term azithromycin treatment

  • Journal Club
  • Published:
Der Pneumologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Dr. Kolditz erhielt Vortragshonorare der Firmen Novartis, Pfizer, GSK, Actelion und Takeda.

Author information

Authors and Affiliations

  1. Abteilung Pneumologie, Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, Fetscherstr. 74, 01307, Dresden, Deutschland

    M. Kolditz

Authors
  1. M. Kolditz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Kolditz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kolditz, M. Prävention der Exazerbation bei COPD. Pneumologe 9, 285–286 (2012). https://doi.org/10.1007/s10405-012-0577-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-012-0577-z

Search

Navigation